BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20007709)

  • 1. SOCS-6 negatively regulates T cell activation through targeting p56lck to proteasomal degradation.
    Choi YB; Son M; Park M; Shin J; Yun Y
    J Biol Chem; 2010 Mar; 285(10):7271-80. PubMed ID: 20007709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
    Nyakeriga AM; Garg H; Joshi A
    Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Characterization of the Amphioxus Lck and Its Associated Tyrosine Phosphorylation-Dependent Inhibitory LRR Receptor.
    Zhou J; Xiao Z; Zhan Y; Qu X; Mou S; Deng C; Zhang T; Lan X; Huang S; Li Y
    Front Immunol; 2021; 12():656366. PubMed ID: 34149695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.
    Venkitachalam S; Chueh FY; Leong KF; Pabich S; Yu CL
    Oncol Rep; 2011 Mar; 25(3):677-83. PubMed ID: 21234523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56
    Kästle M; Merten C; Hartig R; Kaehne T; Liaunardy-Jopeace A; Woessner NM; Schamel WW; James J; Minguet S; Simeoni L; Schraven B
    Cell Commun Signal; 2020 Nov; 18(1):183. PubMed ID: 33225946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p56Lck tyrosine kinase enhances the assembly of death-inducing signaling complex during Fas-mediated apoptosis.
    Sharif-Askari E; Gaucher D; Halwani R; Ma J; Jao K; Abdallah A; Haddad EK; Sékaly RP
    J Biol Chem; 2007 Dec; 282(49):36048-56. PubMed ID: 17932036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Nef compensates for disorganization of the immunological synapse by inducing trans-Golgi network-associated Lck signaling.
    Pan X; Rudolph JM; Abraham L; Habermann A; Haller C; Krijnse-Locker J; Fackler OT
    Blood; 2012 Jan; 119(3):786-97. PubMed ID: 22123847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
    Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
    Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD45 lacking the catalytic protein tyrosine phosphatase domain modulates Lck phosphorylation and T cell activation.
    Wang Y; Johnson P
    J Biol Chem; 2005 Apr; 280(14):14318-24. PubMed ID: 15687496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
    Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
    Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-ordination of the expression of the protein tyrosine kinase p56(lck) with the pre-T cell receptor during thymocyte development.
    Buckland J; Pennington DJ; Bruno L; Owen MJ
    Eur J Immunol; 2000 Jan; 30(1):8-18. PubMed ID: 10602022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo phosphorylation and conformational opening of the tyrosine kinase Lck act in concert to initiate T cell receptor signaling.
    Philipsen L; Reddycherla AV; Hartig R; Gumz J; Kästle M; Kritikos A; Poltorak MP; Prokazov Y; Turbin E; Weber A; Zuschratter W; Schraven B; Simeoni L; Müller AJ
    Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAOK3 Regulates Canonical TCR Signaling by Preventing Early SHP-1-Mediated Inactivation of LCK.
    Ormonde JVS; Li Z; Stegen C; Madrenas J
    J Immunol; 2018 Dec; 201(11):3431-3442. PubMed ID: 30373850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation.
    Choi YB; Kim CK; Yun Y
    J Immunol; 1999 Nov; 163(10):5242-9. PubMed ID: 10553045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-specific adapter protein inhibits T cell activation by modulating Lck activity.
    Sundvold V; Torgersen KM; Post NH; Marti F; King PD; Røttingen JA; Spurkland A; Lea T
    J Immunol; 2000 Sep; 165(6):2927-31. PubMed ID: 10975797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engagement of T-cell antigen receptor and CD4/CD8 co-receptors induces prolonged STAT activation through autocrine/paracrine stimulation in human primary T cells.
    Chueh FY; Yu CL
    Biochem Biophys Res Commun; 2012 Sep; 426(2):242-6. PubMed ID: 22935418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lck couples Shc to TCR signaling.
    Fukushima A; Hatanaka Y; Chang JW; Takamatsu M; Singh N; Iwashima M
    Cell Signal; 2006 Aug; 18(8):1182-9. PubMed ID: 16257509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated p56lck directs maturation of both CD4 and CD8 single-positive thymocytes.
    Sohn SJ; Forbush KA; Pan XC; Perlmutter RM
    J Immunol; 2001 Feb; 166(4):2209-17. PubMed ID: 11160274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A p56lck-independent pathway of CD2 signaling involves Jun kinase.
    Sunder-Plassmann R; Reinherz EL
    J Biol Chem; 1998 Sep; 273(37):24249-57. PubMed ID: 9727049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.